ResMed Inc.
RMD
Rang în acțiuni
#707
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Preț acțiune
$245.63
Capitalizare de piață
$34.54B
Schimbare (1 zi)
2.49%
Schimbare (1 an)
-9.50%
Țară
US
Tranzacționează ResMed Inc. (RMD)
Categorie
Healthcare
Raport P/E pentru ResMed Inc. (RMD)
Raport P/E la data de October 2026 TTM: 22.54
Conform celor mai recente rapoarte financiare și prețului acțiunilor ResMed Inc., raportul P/E actual (TTM) este 22.54. La sfârșitul anului 2024, compania avea un P/E de 26.92.
Istoricul raportului P/E pentru ResMed Inc. din 2000 până în 2026
Raportul P/E la sfârșitul fiecărui an
| An | Raport P/E | Schimbă |
|---|---|---|
| 2026 (TTM) | 22.54 | -16.59% |
| 2025 | 27.02 | 0.38% |
| 2024 | 26.92 | -24.65% |
| 2023 | 35.73 | -9.05% |
| 2022 | 39.28 | -47.96% |
| 2021 | 75.49 | 69.35% |
| 2020 | 44.58 | 1.83% |
| 2019 | 43.78 | -6.58% |
| 2018 | 46.86 | 45.70% |
| 2017 | 32.16 | 27.81% |
| 2016 | 25.16 | 12.14% |
| 2015 | 22.44 | 8.16% |
| 2014 | 20.75 | -0.27% |
| 2013 | 20.80 | 16.45% |
| 2012 | 17.86 | -14.08% |
| 2011 | 20.79 | -13.89% |
| 2010 | 24.14 | 14.81% |
| 2009 | 21.03 | -16.13% |
| 2008 | 25.07 | -47.48% |
| 2007 | 47.74 | 24.01% |
| 2006 | 38.49 | 10.09% |
| 2005 | 34.97 | 16.65% |
| 2004 | 29.97 | 5.79% |
| 2003 | 28.33 | 18.64% |
| 2002 | 23.88 | -82.35% |
| 2001 | 135.33 | 272.77% |
| 2000 | 36.30 | 0.00% |
Raportul P/E pentru companii similare sau concurenți
| Companie | P/E Ratio | Diferență P/E Ratio | Țara |
|---|---|---|---|
| 33.11 | 46.91% |
US
|
|
| 21.39 | -5.10% |
IE
|
|
| 28.94 | 28.43% |
US
|
|
| 17.34 | -23.07% |
US
|
|
| - | - |
DE
|
Cum interpretezi un P/E ratio?
Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.
Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.
Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.